Guobang Pharma Ltd. (SHA:605507)

China · Delayed Price · Currency is CNY

28.26

-0.30 (-1.05%)

Feb 24, 2026, 11:29 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Active Pharmaceutical Ingredient (API)	2.48B	-	-	-				1.25B
Key Pharmaceutical Intermediates	1.13B	-	-	-				816.81M
Pharmaceutical Preparations	213.84M	-	-	-				115.47M
Animal Health APIs	1.83B	-	-	-				596.32M
Animal Health Additives and Preparations	185.99M	-	-	-				115.65M
Others	28.26M	-	-	-				-
Total	5.87B	-	-	-				2.89B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	3.20B	-	-	-				1.64B
Overseas	2.66B	-	-	-				-
Asia	-	-	-	-				760.72M
Europe	-	-	-	-				357.13M
America	-	-	-	-				123.35M
Others	-	-	-	-				17.73M
Total	5.87B	-	-	-				2.89B

Source: S&P Global Market Intelligence.